ArticleRSC advances2026
Fabrication of self-assembled CuO nanosheets for the sustainable synthesis of 2-substituted 1,3-benzothiazoles.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the rapid, sustainable, facile, environmentally friendly synthesis of copper oxide nanosheets (CuO NSs) and their application as a nanocatalyst for the synthesis of 2-substituted 1,3-benzothiazoles. The CuO NSs were characterized by various analytical techniques, including UV-Vis, fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and energy-dispersive X-ray spectroscopy (EDS) mapping. CuO NSs were successfully utilized in the environmentally-friendly synthesis of biologically active 2-substituted 1,3-benzothiazole derivatives in an aqueous ethanol medium. The desired products were obtained in excellent yields without the formation of side products. The synthetic efficacy of this compound is underscored by its high-yielding protocol across a diverse range of substrates and ability to operate under mild reaction conditions. The nanosheet morphology of CuO provides abundant active sites, enabling exceptional catalytic efficiency. The catalyst is readily recoverable and reusable over multiple cycles without significant loss of activity. This operationally simple strategy combines high atom economy, excellent recyclability, and environmentally benign conditions, offering a valuable route to benzothiazole frameworks of pharmaceutical and industrial relevance.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.